NYSE: DHR
Healthcare · Medical - Diagnostics & Research
Market Cap
$117.48B
52w High
$242.80
52w Low
$163.32
P/E
31.85
Volume
6.53M
Outstanding Shares
707.77M
Price vs Fundamentals
The stock fell 15.57% over the last year. Revenue grew 4.02% over the trailing twelve months. Operating margin moved from 21.67% to 20.95%. Free cash flow grew 7.94% over the trailing twelve months.
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
Operating margin currently stands at 20.95%. A decisive move in revenue — currently up 4.02% — would be the clearest signal to resolve the ambiguity.
Company profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
Valuation
Stock splits
Every 125 shares became 141
Every 1000 shares became 1319
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
31
Buy
10
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 28, 2026
Q3 FY26 · EPS est $1.85 · Revenue est $6.09B
View
Dividends
$1.44/shareQuarterly9yr growth streakSafeDHR pays a dividend with a 0.87% declared yield, 9 consecutive years of growth, growing at 15.8% annually, covered 6.0× by free cash flow.
Declared Yield
0.87%
Annual Div / Share
$1.44
TTM $1.36
5yr CAGR
+15.8%
Doubles every ~4.7yr
Payout Ratio
24.67%
Safe
Dividend Growth Rate
3yr CAGR
+16.02%
5yr CAGR
+15.8%
10yr CAGR
-24.79%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$1/mo
In 5 yrs
$1/mo
In 10 yrs
$2/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$9/yr $1/mo | $15/yr+76% $1/mo | $27/yr+211% $2/mo |
Long-range projections use a capped 12% annual growth assumption.
Yield-on-cost grows from 0.87% → 2.69% over 10yr
Analysis
Well-covered by free cash flow
The dividend is covered 6.0× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 15.8% meaningfully outpaces inflation, compounding real income growth for long-term holders.
No strong risk signal stands out from the latest period pair.
Congressional Activity
STOCK Act disclosures from senators and representatives.
| Member | Date | Type | Amount | Filed After |
|---|---|---|---|---|
Michael McCaul TXhouseRepublican | 2026-03-05 | PurchaseSpouse | $1,001 - $15,000 | 36d |
Michael McCaul